Alaska Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Does Excluding High-Risk TAVR Patients Improve Hospital-Level Performance Metrics? | NCDR Study
  Excluding TAVR patients with the highest risk did not improve hospital-level, risk-adjusted outcomes, according to a recent study published in Circulation: Cardiovascular Interventions.
• Unpacking CV Nutritional Controversies in 2026 | JACC: Advances State-of-the-Art Review
  In response to increased controversy over what makes up a healthy diet, a recent JACC: Advances State-of-the-Art Review dives into the evidence both for and against several controversial foods and provides recommendations based on the available literature on cardiovascular health and outcomes.
• No Direct Link Between Statins and Potential Treatment Effects | Meta-Analysis
  A meta-analysis of individual patient data on all adverse events in large-scale, long-term trials of statin therapy found increases in hepatic transaminase and other liver function tests related to statin intensity, but found no evidence that statins cause the majority (62 of 66) of other adverse effects listed in statin labeling...
• BLESS: Ancient Mind-Body Practice Proven to Lower BP
  A traditional Chinese mind-body practice that combines slow, structured movement, deep breathing and meditative focus lowered blood pressure (BP) as effectively as brisk walking, according to results of the BLESS trial published Feb. 18 in JACC. BP reductions were seen after three months and sustained for one year.
• VERITAS: Amulet 360 LAAO Safe, Effective
  The Amulet 360, Abbott's next-generation dual-seal left atrial appendage occlusion (LAAO) device, is effective and safe at 45 days according to the results of the VERITAS study published Feb. 6 in JACC: Clinical Electrophysiology.